Testing Decision Level (DL) and Minimum Detectable Amount (MDA) for Hanford In Vivo Counting Systems.

Health Phys

Hanford Mission Integration Solutions, Radiological Site Service, PO Box 650, MSIN S3-28, Richland, WA 99352.

Published: December 2021

Testing the decision level (DL) and minimum detectable amount (MDA) of a radionuclide for a direct bioassay (in vivo) counting system is a requirement for in vivo monitoring programs across the DOE complex. Bottle manikin absorption (BOMAB) and torso phantoms are used in conjunction with point sources to facilitate the testing. This paper describes a method of testing the DL and MDA values of in vivo counting systems with equipment commonly used by in vivo programs. This method is cost effective and minimizes waste since the radiological sources used can have broad ranges for decay activities. The results from the testing indicated that the current DL and MDA values are valid for the equipment and methods used at the Hanford in vivo counting facility.

Download full-text PDF

Source
http://dx.doi.org/10.1097/HP.0000000000001463DOI Listing

Publication Analysis

Top Keywords

vivo counting
16
testing decision
8
decision level
8
level minimum
8
minimum detectable
8
detectable amount
8
amount mda
8
hanford vivo
8
counting systems
8
mda values
8

Similar Publications

Purpose: In locations where the proton energy spectrum is broad, lineal energy spectrum-based proton biological effects models may be more accurate than dose-averaged linear energy transfer (LET) based models. However, the development of microdosimetric spectrum-based biological effects models is hampered by the extreme computational difficulty of calculating microdosimetric spectra. Given a precomputed library of lineal energy spectra for monoenergetic protons, a weighted summation can be performed which yields the lineal energy spectrum of an arbitrary polyenergetic beam.

View Article and Find Full Text PDF

Study on the metastatic mechanism of LINC00115 in adenocarcinoma of the Esophagogastric junction.

Hum Mol Genet

January 2025

Department of Thoracic Surgery, Huaihe Hospital of Henan University, No. 8, Baobei Road, Gulou District, Kaifeng City, Henan Province, China.

Adenocarcinoma of the esophagogastric junction (AEG) is a common and deadly cancer, and an in-depth investigation of its molecular mechanisms of metastasis is crucial for discovering new therapeutic targets. This study explores the role of the long non-coding RNA (lncRNA) LINC00115 in AEG metastasis and its underlying mechanisms. Through the analysis of 108 pairs of AEG cancer tissues and matched adjacent tissues, we found a significant upregulation of LINC00115 in AEG tissues, closely associated with TNM staging and lymph node metastasis.

View Article and Find Full Text PDF

Aluminum Induces Neurotoxicity through the MicroRNA-98-5p/Insulin-like Growth Factor 2 Axis.

ACS Chem Neurosci

January 2025

Department of Occupational Health, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China.

Aluminum is a well-known and widely distributed environmental neurotoxin. This study aimed to investigate the effect of miR-98-5p targeting insulin-like growth factor 2 (IGF2) on aluminum neurotoxicity. Thirty-two Sprague-Dawley rats were randomly divided into four groups and administered 0, 10, 20, and 40 μmol/kg maltol aluminum [Al(mal)], respectively.

View Article and Find Full Text PDF

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer, and immune checkpoint inhibitors (ICIs) have shown efficacy in its treatment. The combination of chemotherapy and ICIs represents a new trend in the standard care for metastatic NPC. In this study, we aim to clarify the immune cell profile and related prognostic factors in the ICI-based treatment of metastatic NPC.

View Article and Find Full Text PDF

Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway.

Drug Des Devel Ther

January 2025

Department of Trauma Orthopedics, Affiliated Hospital of Jining Medical University, Jining, Shandong, 272007, People's Republic of China.

Purpose: Osteosarcoma (OS) is the most common malignant tumor associated with poor patient outcomes and a limited availability of therapeutic agents. Scutellarein (SCU) is a monomeric flavone bioactive compound with potent anti-cancer activity. However, the effects and mechanisms of SCU on the growth of OS remain unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!